Pulse Biosciences appoints Mitchell E. Levinson as Chief Strategy Officer

PULSE BIOSCIENCES, INC.

Appointment effective August 19, 2021; Levinson continues as board member.
He brings 30+ years in med device, co-founded Cerebrotech and was early Zeltiq employee.
Role is newly created; company plans multi-specialty expansion using CellFX platform.
No financial guidance or earnings changes announced in the filing.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Mitchell E. Levinson

Chief Strategy Officer

PLSE · PULSE BIOSCIENCES, INC.

Effective: 2021-08-19
Filed: August 20, 2021, 7:59 PM ET

On August 19, 2021, Pulse Biosciences, Inc. (the “Company”) announced the appointment of Mitchell E. Levinson to the newly created role of Chief Strategy Officer, effective immediately, in addition to the continuation of his role as a member of the Company’s Board of Directors.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Mitchell E. Levinson was appointed as Chief Strategy Officer at PULSE BIOSCIENCES, INC..

Action: appointed
Role: Chief Strategy Officer

Exact text from the filing

On August 19, 2021, Pulse Biosciences, Inc. (the “Company”) announced the appointment of Mitchell E. Levinson to the newly created role of Chief Strategy Officer, effective immediately, in addition to the continuation of his role as a member of the Company’s Board of Directors.

View on SEC.gov

PULSE BIOSCIENCES, INC. filing history →

Source: SEC EDGAR

accession 0001625101-21-000044

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.